Shire’s Vyvanse Approved For ADHD

Firm will launch the drug in the second quarter pending final DEA clearance as a Schedule II controlled substance.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet